Motiva SmoothSilk Round Ergonomix Silicone Gel-Filled Breast Implants, Motiva SmoothSilk Round Silicone Gel-Filled Breas
Motiva USA, LLC · Decision date Sep 26, 2024
What did the FDA approve?
FDA approved PMA P230005 for Motiva SmoothSilk Round and SmoothSilk Round Ergonomix silicone gel-filled breast implants. The approval statement lists the indication as breast augmentation for women at least 22 years old, including primary augmentation to increase breast size and revision surgery to correct or improve the result of an original primary augmentation.
The device category is a noninflatable internal silicone gel-filled breast prosthesis under product code FTR. The applicant is Motiva USA, LLC, and the decision date is September 26, 2024. The source statement does not include safety or effectiveness findings, clinical trial data, or a supplement relationship to any earlier PMA.
FDA approval order statement
The Motiva SmoothSilk Round and SmoothSilk Round Ergonomix breast implants are indicated for breast augmentation for women of at least 22 years old. Breast augmentation includes primary breast augmentation to increase the breast size, as well as revision surgery to correct or improve the result of an original primary breast augmentation surgery (i.e., revision-augmentation).
- Regulatory pathway
- Original PMA
- Clinical specialty
- General, Plastic Surgery
- Decision date
- Sep 26, 2024
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P230005
- Regulatory pathway
- Premarket approval application
- Applicant
- Motiva USA, LLC
- Product code
- FTR
- Decision code
- APPR
- Decision date
- Sep 26, 2024
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Prosthesis, breast, noninflatable, internal, silicone gel-filled.
- Applicant
- Motiva USA, LLC
- Product code
- FTR
- FDA device class
- 3
The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.
FDA decision timeline
P230005 received
Application receipt date recorded by FDA.
P230005 · FDA decision
APPR
P230005/S005 · Related supplement
Motiva SmoothSilk Round and Round Ergonomix Silicone Gel-Filled Breast Implants
P230005/S002 · Related supplement
Motiva SmoothSilk Round Ergonomix Silicone Gel-Filled Breast Implants, Motiva SmoothSilk Round Silicone Gel-Filled Breas
Timeline entries are records held by MedtechLedger for P230005. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P230005
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Motiva USA, LLC | PMA supplement | Sep 25, 2026 | FDA | |
| Motiva USA, LLC | PMA supplement | Oct 2, 2026 | FDA |
Explore the linked device profile
Other records with product code FTR
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Sientra Silicone Gel Breast ImplantsP070004/S049 | Tiger Aesthetics Medical, LLC | PMA supplement | Nov 4, 2026 | FDA |
MemoryGel Breast ImplantsP030053/S093 | Mentor Corp. | PMA supplement | Oct 23, 2026 | FDA |
MemoryShape Breast ImplantsP060028/S063 | Mentor Worldwide, LLC | PMA supplement | Oct 23, 2026 | FDA |
| Allergan | PMA supplement | Sep 29, 2026 | FDA | |
| Mentor Worldwide, LLC | PMA approval | Jun 14, 2013 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Motiva USA, LLC
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 2543 Mesa School Ln., Santa Barbara, CA, 93109
Sources and methodology
- Original FDA record: P230005
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records




